Close Menu

NEW YORK – Microbiology testing and diagnostics firm PathoQuest today announced the closing of an €8 million ($8.9 million) financing round.

The funding includes a loan from Norgine Ventures and financing from previous investors Kurma Partners, Idinvest Partners, and Charles River Labs, as well as new investor Investiere.

The money includes €427,000 in non-dilutive funding from the French public investment program Investissement d'Avenir concours d'innovation i-Nov.

Other details, including PathoQuest's intended use of the funds, were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.